Literature DB >> 8387880

Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry.

M Ponz de Leon1, R Sassatelli, P Benatti, L Roncucci.   

Abstract

BACKGROUND: Hereditary nonpolyposis colorectal cancer (HNPCC or Lynch syndrome) is an autosomal dominant disease characterized by early-onset intestinal neoplasms, localization of tumors in the proximal colon, and frequent association with cancers at other sites, especially the endometrium, skin, and stomach. The identification of HNPCC is often difficult, owing to the lack of biomarkers and the extreme frequency of sporadic colorectal cancer in the Western World.
METHODS: The authors reviewed the clinical data and the family trees of all patients (n = 817) with colorectal malignancies registered in the local health district between 1984-1989 with the following objectives: (1) to identify families with HNPCC and (2) to establish the frequency of the syndrome in northern Italy. Six clinical criteria were defined (vertical transmission, familial aggregation, early age at onset, right colon localization, multiple tumors, and mucinous carcinoma), all indicative of an increased possibility of HNPCC:
RESULTS: The registered families were divided into various subgroups according to the presence (in the nuclear pedigree) of four or more criteria (41 families, 5.0% of total), three criteria (58 families, 7%), two criteria (73, 8.9%), or less than two criteria (203 families, 24.8%). The remaining 380 case families did not show criteria suggesting a genetic component. One hundred thirty-three genealogic trees were extended further to gather information on second-degree and third-degree relatives. The expanded pedigrees were further analyzed to ascertain if they met the recently proposed requisites for HNPCC: Nineteen of 37 (51%) families with four criteria met the minimum requisites and could therefore be considered HNPCC: Similarly, HNPCC was diagnosed in six extended pedigrees of the three-criteria (16.6%) and in three families (8.5%) of the two-criteria subgroups. The difference in the detection of HNPCC among various subgroups was statistically significant (P < 0.001). From the observed findings, the frequency of HNPCC in this population can be estimated to be between 3.4-4.5% of all cases of colorectal cancer.
CONCLUSIONS: HNPCC can be identified in the general population through the data of a colorectal cancer registry if the nuclear pedigrees of all incident cases are traced and a proportion of them selectively expanded. The observed frequency of HNPCC was rather consistent with previous estimates in other populations.

Entities:  

Mesh:

Year:  1993        PMID: 8387880     DOI: 10.1002/1097-0142(19930601)71:11<3493::aid-cncr2820711106>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

Review 1.  Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Authors:  Vaishali B Patel; Sabeena Misra; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study.

Authors:  Carmela Di Gregorio; Piero Benatti; Lorena Losi; Luca Roncucci; Giuseppina Rossi; Giovanni Ponti; Massimiliano Marino; Monica Pedroni; Alessandra Scarselli; Barbara Roncari; Maurizio Ponz de Leon
Journal:  Int J Colorectal Dis       Date:  2004-12-09       Impact factor: 2.571

Review 3.  The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism.

Authors:  Basil Rigas; George J Tsioulias
Journal:  J Pharmacol Exp Ther       Date:  2015-04       Impact factor: 4.030

Review 4.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

Review 5.  The incidence of Lynch syndrome.

Authors:  Albert de la Chapelle
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

6.  Aetiology of colorectal cancer and relevance of monogenic inheritance.

Authors:  M Ponz de Leon; P Benatti; F Borghi; M Pedroni; A Scarselli; C Di Gregorio; L Losi; A Viel; M Genuardi; G Abbati; G Rossi; M Menigatti; I Lamberti; G Ponti; L Roncucci
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

7.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

Review 8.  [Molecular pathology in hereditary colorectal cancer. Recommendations of the Collaborative German Study Group on hereditary colorectal cancer funded by the German Cancer Aid (Deutsche Krebshilfe)].

Authors:  J Rüschoff; B Roggendorf; F Brasch; M Mathiak; D E Aust; J Plaschke; W Mueller; C Poremba; M Kloor; G Keller; M Muders; S Blasenbreu-Vogt; P Rümmele; A Müller; R Büttner
Journal:  Pathologe       Date:  2004-05       Impact factor: 1.011

9.  Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry.

Authors:  Fáblio Oliveira Ferreira; Claudia Cristina Napoli Ferreira; Benedito Mauro Rossi; Wilson Toshihiko Nakagawa; Samuel Aguilar; Erika Maria Monteiro Santos; Marcelo Leite Vierira Costa; Ademar Lopes
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 10.  Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impact.

Authors:  Karin M Landsbergen; Judith B Prins; Han G Brunner; Floris W Kraaimaat; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2009-03-28       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.